Two Sigma Advisers’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-19,948
Closed -$25.1K 2630
2023
Q2
$25.1K Sell
19,948
-140,667
-88% -$228K ﹤0.01% 2316
2023
Q1
$321K Buy
160,615
+66,400
+70% +$125K ﹤0.01% 2111
2022
Q4
$124K Buy
94,215
+51,100
+119% +$65.2K ﹤0.01% 2271
2022
Q3
$35K Sell
43,115
-35,333
-45% -$30.4K ﹤0.01% 2401
2022
Q2
$77K Sell
78,448
-18,400
-19% -$24.3K ﹤0.01% 2424
2022
Q1
$187K Sell
96,848
-55,200
-36% -$119K ﹤0.01% 2397
2021
Q4
$333K Sell
152,048
-29,328
-16% -$97.5K ﹤0.01% 2106
2021
Q3
$675K Sell
181,376
-115,900
-39% -$495K ﹤0.01% 1794
2021
Q2
$1.78M Buy
297,276
+33,300
+13% +$176K ﹤0.01% 1346
2021
Q1
$1.74M Buy
263,976
+46,900
+22% +$308K ﹤0.01% 1339
2020
Q4
$1.22M Sell
217,076
-11,600
-5% -$63.7K ﹤0.01% 1474
2020
Q3
$1.07M Buy
228,676
+73,913
+48% +$525K ﹤0.01% 1477
2020
Q2
$1.8M Sell
154,763
-5,562
-3% -$66K 0.01% 1255
2020
Q1
$923K Buy
160,325
+82,462
+106% +$738K ﹤0.01% 1528
2019
Q4
$1.06M Buy
77,863
+61,567
+378% +$544K ﹤0.01% 1548
2019
Q3
$122K Sell
16,296
-800
-5% -$4.99K ﹤0.01% 2097
2019
Q2
$103K Sell
17,096
-4,700
-22% -$29.3K ﹤0.01% 2213
2019
Q1
$153K Sell
21,796
-2,800
-11% -$14.6K ﹤0.01% 2153
2018
Q4
$87K Buy
24,596
+113
+0.5% +$650 ﹤0.01% 2231
2018
Q3
$206K Sell
24,483
-2,150
-8% -$22.7K ﹤0.01% 2073
2018
Q2
$324K Sell
26,633
-217
-0.8% -$2.23K ﹤0.01% 2076
2018
Q1
$266K Buy
26,850
+900
+3% +$10.1K ﹤0.01% 2057
2017
Q4
$343K Buy
25,950
+10,117
+64% +$130K ﹤0.01% 1900
2017
Q3
$233K Buy
+15,833
New +$1.6M ﹤0.01% 2009
2017
Q2
Sell
-3,183
Closed -$408K 2442
2017
Q1
$408K Buy
+3,183
New +$336K ﹤0.01% 1974

Other funds holding ARAV

Two Sigma Advisers's ARAV Position: Q3 2023 in Review

Two Sigma Advisers sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2023, closing a stake of 19,948 shares — an estimated $25.1K sold.

Two Sigma Advisers first reported a position in ARAV in Q1 2017 and held it in 25 quarters. The position peaked at $1.8M in Q2 2020. 33 funds tracked by Wall St. Rank hold ARAV as of Q3 2023.

  • Two Sigma Advisers reported no remaining Aravive, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 19,948 Aravive, Inc. Common Stock shares in Q3 2023, an estimated $25.1K.
  • Two Sigma Advisers first reported a position in Aravive, Inc. Common Stock in Q1 2017 and held it in 25 quarters.
  • Two Sigma Advisers's Aravive, Inc. Common Stock position peaked at $1.8M in Q2 2020.
  • 33 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.